B.C. health authorities have announced the first case of a human avian flu infection acquired in Canada, with the teenage patient in critical condition in hospital.
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).